1. Home
  2. EGRX vs LEE Comparison

EGRX vs LEE Comparison

Compare EGRX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EGRX
  • LEE
  • Stock Information
  • Founded
  • EGRX 2007
  • LEE 1890
  • Country
  • EGRX United States
  • LEE United States
  • Employees
  • EGRX N/A
  • LEE N/A
  • Industry
  • EGRX Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • EGRX Health Care
  • LEE Consumer Discretionary
  • Exchange
  • EGRX Nasdaq
  • LEE Nasdaq
  • Market Cap
  • EGRX 50.7M
  • LEE 53.9M
  • IPO Year
  • EGRX 2014
  • LEE N/A
  • Fundamental
  • Price
  • EGRX $1.99
  • LEE $8.83
  • Analyst Decision
  • EGRX
  • LEE
  • Analyst Count
  • EGRX 0
  • LEE 0
  • Target Price
  • EGRX N/A
  • LEE N/A
  • AVG Volume (30 Days)
  • EGRX 321.6K
  • LEE 14.5K
  • Earning Date
  • EGRX 11-12-2024
  • LEE 08-01-2024
  • Dividend Yield
  • EGRX N/A
  • LEE N/A
  • EPS Growth
  • EGRX N/A
  • LEE N/A
  • EPS
  • EGRX 0.91
  • LEE N/A
  • Revenue
  • EGRX $257,551,000.00
  • LEE $616,815,000.00
  • Revenue This Year
  • EGRX N/A
  • LEE N/A
  • Revenue Next Year
  • EGRX N/A
  • LEE N/A
  • P/E Ratio
  • EGRX $2.35
  • LEE N/A
  • Revenue Growth
  • EGRX N/A
  • LEE N/A
  • 52 Week Low
  • EGRX $1.80
  • LEE $7.56
  • 52 Week High
  • EGRX $14.78
  • LEE $15.89
  • Technical
  • Relative Strength Index (RSI)
  • EGRX 19.60
  • LEE 52.42
  • Support Level
  • EGRX $1.80
  • LEE $8.54
  • Resistance Level
  • EGRX $4.11
  • LEE $9.41
  • Average True Range (ATR)
  • EGRX 0.40
  • LEE 0.32
  • MACD
  • EGRX -0.19
  • LEE 0.09
  • Stochastic Oscillator
  • EGRX 6.86
  • LEE 58.28

About EGRX Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.

Share on Social Networks: